Jubilant Organosys Limited
FY 09 VS FY 10
RESULTS REVIEW
Jubilant organosys has produced better performance in FY 10 compared to FY 09.
Net sales has increased marginally from Rs.2430.72 crores in FY 09, to Rs. 2446.20 Cr in FY10
But, raw material cost has decreased from Rs.1432.15 Cr in FY 09 to Rs. 1368.98 Cr during the same period. Thus, the total expenditure has also decreased from Rs. 2083.52 Cr in FY 09 to Rs.1890.09 Cr in FY 10.
Consequently, Net profit has increased from Rs.260.74 Cr in FY 09 to Rs.363.10 Cr in FY 10.
The company has increased dividend from 150% last year to 200 % in FY 10.
On a Face Value of Rs. 1/-, the ANNUAL EPS has gone up from Rs.17.7 in FY 09 to Rs. 24.6 in FY 10. This is a significant increase. On a market price of Rs.343, the PE ratio works out to 13.94, which leaves scope for price appreciation.
QUARTERLY RESULTS
On a quarterly basis, the Basic EPS is Rs.6.23 for q/e 03/10, compared to Rs.4.78 for q/e 12/09; Rs.3.76 for q/e 09/09; Rs.9.83 for q/e 06/09 and rs.-1.04 for q/e 03/09. While profits are good, there is no significant increase QOQ.
Net Sales during the same periods are Rs. 600.41 Cr; Rs.612.49; Rs. 627.36 Cr; Rs. 605.94 Cr; and Rs. 548.06 Cr. Thus, quarterly sales do not show any increase.
CONSOLIDATED BASIS
The company has said that –
"Q4 FY2010- Consolidated Revenue up by 18% to Rs.990 crore; EBITDA up 115% to Rs.227 crore; PAT up 10 times at Rs. 137 crore;
FY2010- Consolidated Revenue up by 8% to Rs.3,781 crore; EBITDA up 34% to Rs.826 crore; PAT up 49% at Rs. 421 crore; Board recommends dividend of 200%".
RESULTS IN NUMBERS
Annual,cumulative,non-consolidated
FY 09 (Rs. in lakhs) :: Description :: FY 10(Rs. in lakhs)
243072 Net Sales :: 244620
1138 Other Operating Income :: 1414
-2811 Increase/Decrease in SIT & WIP :: -1646
143215 Raw Materials :: 136898
10668 Purchase of traded goods :: 17531
15600 Employees Cost :: 17600
7462 Depreciation :: 6510
34218 Other Expenditure :: 12116
208352 Total Expenditure :: 189009
35858 Profit from Operations :: 57025
674 Other Income 1154
36532 Profit before Interest & Exceptional Items :: 58179
5435 Interest :: 9971
31097 Profit after Interest &before Exceptional Items :: 48208
3794 Exceptional items :: 2281
27303 P B T :: 45927
1229 Tax Expense :: 9617
26074 P A T :: 36310
26074 Net Profit (+) :: 36310
150 Dividend (%) :: 200
1 Face Value (in Rs.) :: 1
1475 Paid-up Equity :: 1588
132463 Reserves :: 215697
17.7 Basic EPS :: 24.6
15.25 Diluted EPS:: 21.24
ANNOUNCEMENTS TO THE EXCHANGE
10-05-2010 Jubilant Organosys Limited has informed the Exchange that at a Meeting of the Compensation Committee of the Board of Directors held on May 10, 2010, pursuant to exercise of 51,532 options, the Committee has approved transfer by Jubilant Employees Welfare Trust to the option holders, of equity shares of Re. 1 each at an exercise price of: (1) Rs. 201.33 per share for 2,56,860 equity shares and (2) Rs. 198.55 per share for 800 equity shares. -
10-05-2010 Jubilant Organosys Limited has informed the Exchange regarding a press release dated May 10, 2010, titled "Q4 FY2010- Consolidated Revenue up by 18% to Rs.990 crore; EBITDA up 115% to Rs.227 crore; PAT up 10 times at Rs. 137 crore; FY2010- Consolidated Revenue up by 8% to Rs.3,781 crore; EBITDA up 34% to Rs.826 crore; PAT up 49% at Rs. 421 crore; Board recommends dividend of 200%". Click Here
10-05-2010 Jubilant Organosys Limited has informed the Exchange that the Board of Directors at its meeting held on May 10, 2010 has recommended a dividend of Rs. 2.00 per equity shares of Rs.1 amounting to Rs.3703 Lacs, subject to approval in the annual general meeting. -
10-05-2010 Jubilant Organosys Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 60041 lacs for quarter ending on 31-MAR-2010 against Rs. 54806 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 9201 lacs for the quarter ending on 31-MAR-2010 against Rs. (1529) lacs for the quarter ending on 31-MAR-2009. -
10-05-2010 Jubilant Organosys Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 99032 lacs for quarter ending on 31-MAR-2010 against Rs. 84124 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 13716 lacs for the quarter ending on 31-MAR-2010 against Rs. 1237 lacs for the quarter ending on 31-MAR-2009. -
10-05-2010 Jubilant Organosys Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 244620 lacs for year ending on 31-MAR-2010 against Rs. 243072 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 36310 lacs for the year ending on 31-MAR-2010 against Rs. 26074 lacs for the year ending on 31-MAR-2009. -
10-05-2010 Jubilant Organosys Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 378127 lacs for year ending on 31-MAR-2010 against Rs. 351798 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 42146 lacs for the year ending on 31-MAR-2010 against Rs. 28318 lacs for the year ending on 31-MAR-2009.
01-04-2010 Jubilant Organosys Limited has informed the Exchange vide its letter dated March 31, 2010 that "The Capital Issue Committee, a duly authorized committee of the Board of Directors of the Company (the 'Committee') had approved the price for issue of shares to Qualified Institutional Buyers, the Bid Closing Date and Placement Document in respect of such issue, the Committee at its meeting held today, has approved the allotment of 11,237,517 equity shares of Re. 1/- each at a price of Rs. 344.50 per share, aggregating to Rs. 387.13 crores to Qualified Institutional Buyers under Chapter VIII of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended, against receipt of full payment of application monies in the escrow cash account opened by the Company". A copy of resolution passed at the meeting of the Capital Issue Committee of the Board of Directors held on March 31, 20010 shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
No comments:
Post a Comment